Skip to content
Events

Details

TruPath™ Genome– an exciting new approach to obtain deeper insights into the genome

Explore the latest advances in Illumina’s next generation sequencing technology and how they are reshaping clinical research. This session introduces the newly launched TruPath™ Genome workflow, designed for high-resolution detection of complex variants—including structural variation and haplotype phasing—that are essential for understanding disease mechanisms.

You’ll hear directly from one of the developers behind TruPath Genome and see how the workflow has been applied in a clinical research setting to enhance detection of Lynch syndrome. The session offers practical insights into improving variant detection accuracy and supporting more informed decision making in genomic studies.

Speakers:

Simeen Malik
Director of Bioinformatics
Illumina

Simeen Malik, Director of Bioinformatics at Illumina Singapore, leads teams developing Illumina’s software and clinical genomic data solutions. She specializes in large scale datasets, machine learning, and bioinformatics support for major national genomics initiatives, including PRECISE. Her prior roles span Merck, Duke NUS, and contributions to TCGA and other high impact studies.

Alvin Ng
Postdoctoral Fellow
NTU

Dr Alvin Ng is a Dean’s Postdoctoral Fellow at the Lee Kong Chian School of Medicine, where he uses advanced sequencing technologies to study mutational processes in cancer. He recently joined Prof Joanne Ngeow’s lab to investigate DNA repair–related cancers, including colorectal, breast, and ovarian. Trained in computational biology at Duke NUS, Alvin has developed tools for detecting mutational signatures and has led research on structural variants and extrachromosomal DNA during his postdoctoral work at the Early Cancer Institute, Cambridge.

Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
30 May 2026
Location
South APAC
Affiliation
Illumina and NTU
Presenter
Simeen Malik and Alvin Ng
Topic
Complex disease genomics, Genetic & rare diseases
Register
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.